In a study published May 15 in the New England Journal of Medicine and presented at the American Society of Gene and Cell ...

CRISPR Therapeutics, whose CEO is Samarth Kulkarni, and Vertex Pharmaceuticals earned the first U.S. Food and Drug ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

The Michigan Sickle Cell Data Collection Program has been tracking information from the estimated 4,000 Michigan residents ...

Beam Therapeutics will present new BEAM-101 data for sickle cell disease at EHA2025, detailing safety and efficacy in 17 patients. Beam Therapeutics Inc. has announced that it will present updated ...

Sickle cell disease is more serious and can lead to problems such as organ damage, strokes and anemia. By contrast, those with sickle cell trait “typically live normal lives,’’ according to ...

A Bahrain study shows CT scans to check for blood clots in lung blood vessels increased significantly in people with sickle ...

Bhopal: Governor Mangubhai Patel inaugurated the genetic analysis laboratory and DNA sequencer machine at BMHRC's sickle cell anaemia competence centre. He also launched a seminar titled "Genetic ...

The quality of life of patients with sickle cell anemia is severely compromised similar to or even worse than patients with other chronic diseases such as arthritis. Patients who responded to ...

Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET ...